
Piramal Pharma to Invest $90 Million at Kentucky & Michigan Sites
Responding to what it called a trend toward United States onshoring of drug supply, Mumbai-based Piramal Pharma announced an investment plan worth $90 million, developed in conjunction with the 2025 SelectUSA Investment Summit, earmarked for two of its US …